spironolactone has been researched along with elastin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobik, A; Funder, J; Kanellakis, P; Ramsey, D; Ward, MR | 1 |
| Benetos, A; Delcayre, C; Labat, C; Lacolley, P; Pujol, A; Safar, M | 1 |
| Bunda, S; Hinek, A; Liu, K; Liu, P; Wang, Y | 1 |
| Amiri, F; Savoia, C; Schiffrin, EL; Touyz, RM | 1 |
| Che, ZQ; Gao, PJ; Han, WQ; Liu, JJ; Wu, LY; Wu, YJ; Zhang, J; Zhou, HY; Zhu, DL | 1 |
| Bunda, S; Hinek, A; Mitts, TF; Wang, Y | 1 |
| Cassis, LA; Daugherty, A; Gong, MC; Guo, Z; Liu, S; Pearson, KJ; Xie, Z | 1 |
1 trial(s) available for spironolactone and elastin
| Article | Year |
|---|---|
Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Arteries; Atenolol; Blood Pressure; Buttocks; Collagen; Diastole; Double-Blind Method; Elasticity; Elastin; Eplerenone; Female; Humans; Hypertension; Inflammation Mediators; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myography; Spironolactone; Subcutaneous Tissue; Systole; Vascular Resistance | 2008 |
6 other study(ies) available for spironolactone and elastin
| Article | Year |
|---|---|
Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.
Topics: Aldosterone; Angioplasty, Balloon; Animals; Collagen; Constriction, Pathologic; Coronary Disease; Coronary Vessels; Elastin; Eplerenone; Iliac Artery; Male; Mineralocorticoid Receptor Antagonists; Spironolactone; Swine; Swine, Miniature; Tunica Intima | 2001 |
Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.
Topics: Aldosterone; Animals; Blood Pressure; Blotting, Northern; Carotid Arteries; Collagen; Collagen Type I; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Elasticity; Elastin; Eplerenone; Fibronectins; Hyperaldosteronism; Immunohistochemistry; Injections, Subcutaneous; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium, Dietary; Spironolactone; Ultrasonography; Vascular Patency | 2002 |
Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.
Topics: Aldosterone; Animals; Cells, Cultured; Collagen Type I; Elastin; Fibroblasts; Gene Expression Regulation; Hormone Antagonists; Humans; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocardium; Phosphorylation; Receptor, IGF Type 1; Receptors, Mineralocorticoid; Spironolactone; Tropoelastin; Tyrosine | 2007 |
Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Collagen; Connective Tissue; Diuretics; Drug Evaluation, Preclinical; Elastin; Hypertension; Losartan; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spironolactone | 2009 |
Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin.
Topics: Adult; Aldosterone; Biopsy; Cells, Cultured; Cicatrix; Collagen Type I; Elasticity; Elastin; Eplerenone; Extracellular Matrix; Female; Fibroblasts; Gene Expression; Humans; Keloid; Mineralocorticoid Receptor Antagonists; Organ Culture Techniques; Receptor, IGF Type 1; RNA, Messenger; Skin; Spironolactone; Up-Regulation | 2010 |
Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Apoptosis; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elastin; Enalapril; Eplerenone; Losartan; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Mineralocorticoid; Sodium Chloride, Dietary; Spironolactone; Time Factors | 2013 |